used CRISPR/Cas9 gene to knock out the uPAR-encoding gene PLAUR in colon cancer cells, resulting in immature mitochondrial development, decreased glycolysis, and increased lactate secretion (32). This evidence concerns the gene PLAUR and malignant colon neoplasm.